Insurances & Business

Merck shares fall on FDA drug rejection, Abbott shares rise (AP)

Business | Sources: Yahoo

Similar/Related/News:

• Cephalon shares fall ahead of FDA panel on pain drug Fentora (AP)
Cephalon Inc. shares fell Friday over concerns that the biotechnology company may face a tougher-than-expected Food and Drug Administration panel revi...
• Novartis shares jump as cancer drug shows promise (AP)
Shares of drug developer Novartis AG jumped Monday after the company said its kidney cancer drug candidate delayed tumor growth twice as long as place...
• ImClone Shares Rise on Pipeline Advance (AP)
Shares of ImClone Systems Inc. rose Thursday following the biotechnology company's announcement it will move a head-and-neck cancer drug candidate int...
• Discovery shares plunge on delay for key drug candidate (AP)
Discovery Laboratories Inc. shares plunged Friday after its key drug candidate faced another regulatory delay with the Food and Drug Administration, f...
• Human Genome Sciences shares fall on drug candidate swap (AP)
Shares of Human Genome Sciences fell Thursday after the biotechnology company bought back the rights to its cancer treatments, a move one analyst said...
• Genentech, Biogen shares dip on late-stage drug failure (AP)
Shares of Genentech Inc. and Biogen Idec Inc. fell Tuesday after the biotechnology companies reported a failure of their drug Rituxan to prompt a resp...
• Ralcorp Shares Fall on Downgrade (AP)
Shares of private-label cereal maker Ralcorp Holdings Inc. fell Thursday after a JPMorgan analyst cut his rating on the shares, saying costs could tri...
• Out of the Gate: QLT climbs after RBC upgrades (AP)
Shares of QLT Inc. rose Thursday after an RBC Capital Markets analyst upgraded the drug maker, saying it is underpriced given a recent divestiture and...